BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 24, 2019
View Archived Issues
Scientists report new telomerase partner protein
Read More
Glutamate receptor predicts suicidality in PTSD
Read More
Injection of CSF from multiple sclerosis patients generates mouse model of cerebellar dysfunction
Read More
New ICOS agonist improves immune checkpoint inhibition in cancer models
Read More
SBIR grant supports Western Oncolytics' development of WO-VET-S3
Read More
Phase III ClarIDHy study of Tibsovo in cholangiocarcinoma meets primary endpoint
Read More
Compass opens first-in-human study of CTX-471 in malignancies that progress on PD-1/PD-L1 inhibitors
Read More
Oral antisense-miRNA-214 as a possible treatment for colitis
Read More
New phase II HopES study to investigate SM-88 in high-risk sarcomas
Read More
Argenx expands pipeline with ARGX-117 and ARGX-118
Read More
APRINOIA Therapeutics awarded Michael J. Fox Foundation grant for Parkinson's research
Read More
Quinolinone SRI-34329 inhibits Venezuelan equine encephalitis virus at micromolar concentrations
Read More
Modulation of PIK3C2B improves vaccination against influenza in PHIV children
Read More
FDA lifts target class clinical hold for lanifibranor
Read More
Softer touch enhances drug delivery efficiency
Read More
GSK-2831781 begins phase II trial in moderate to severe active ulcerative colitis
Read More
ChemoCentryx divulges C5AR1 antagonists
Read More
Amgen discloses APLNR agonists
Read More
Norovirus VLP vaccine TAK-214 immunogenic, well tolerated in phase II study
Read More
GlaxoSmithKline identifies IDO1 inhibitors
Read More
U.S. researchers present ALDH1A1 inhibitors
Read More
FDA grants marketing authorization to Zika virus diagnostic test
Read More
Bioimics identifies bacterial ribonuclease P inhibitors
Read More
Synlogic enters collaboration with Roche to study SYNB-1891 with Tecentriq in advanced tumors
Read More
SBIR grant supports Sentia's development of astressins for IBS
Read More
NIAID begins phase I/II study of RSV vaccines in children aged 6-24 months
Read More
Cyxone to seek clearance for phase I study of MS drug candidate T20K
Read More
